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ChromatographyAbstract The root bark of Cassia abbreviata has been traditionally used by the native population
of the coastal region of Kenya to treat malaria. As part of our ongoing investigations into com-
pounds with activity against malaria parasites, we tested the in vitro antiplasmodial activity against
Plasmodium falciparum strain namely; chloroquine-resistant W2 and chloroquine-sensitive D6. The
methanolic root extract of the plant was active against the chloroquine-sensitive (IC50 = 20.56 lg/
ml) and the chloroquine-resistant (IC50 = 13.31 lg/ml) strains of P. falciparum. Two ﬂavans 1 and
2 were puriﬁed, identiﬁed and further shown to be antiplasmodial. Compound 2 was more active
than compound 1 against both strains of P. falciparum with IC50 values of 8.12 lg/ml (D6);
8.89 lg/ml (W2) and 26.02 lg/ml (D6); 25.97 lg/ml (W2), respectively. This study partly provides
evidence to support the use of C. abbreviata as a malaria remedy, as used by the native populations.
ª 2012 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Cassia abbreviata Oliv. (Fabaceae, Caesalpinioideae), is a
small branchy umbrella-shaped deciduous tree 2–25 m tall,
with a very distinctive cylindrical fruit (Brenan, 1967; Malanet al., 1996). From ethnomedical information root decoction
is used to treat gastrointestinal disorders, malaria, gonorrhea,
pneumonia and as a purgative (Chhabra et al., 1987; Gessler
et al., 1994; Kokwaro, 1993; Mutasa and Kahn, 1995). The
stem bark is used for treating diarrhoea, toothache, abdominal
pains and headache (Pelgrave, 1977; Kokwaro, 1993; Orwa
et al., 2009). Recently C. abbreviata was reported to be used
for diabetes treatment in the lower eastern province in Kenya
(Keter and Mutiso, 2012), which is experimentally demon-
strated by reports of a-glucosidase inhibition and antioxidant
activities of its stembark extract (Shai et al., 2010).
A number of compounds including anthraquinones, triterp-
enoids, alcohols and organic acids have been isolated from the
ﬂowers, leaves, root bark and stem bark of C. abbreviata
(Mutasa and Kahn, 1995). The laxative activity of most Cassia
675 g dry weight of roots of Cassia abbreviata
69 g of methanolic crude extract
10.4 g of intermediate product
62 mg of Compound (1) 80 mg of Compound (2)
Silica gel chromatography
60% CH2Cl2 and 40% MeOH
Figure 1 Puriﬁcation scheme for compounds 1 and 2 from C.
abbreviata.
Antiplasmodial activity of ﬂavan derivatives from rootbark of Cassia abbreviata Oliv. S141species is linked to the anthraquinone emodin and its associ-
ated glycosides (Sakulpanich and Wandee, 2009). Methanolic
extracts of the stem bark antagonized responses to acetylcho-
line and serotonin in a concentration-dependent manner
(Parry and Duri, 1994).
Crude extracts from C. abbreviata parts have been screened
severally for antiplasmodial activity but no pure active
constituent reported (Weenen et al., 1990; Gessler et al.,
1994; Connelly et al., 1996; Malan et al., 1996; Muthaura
et al., 2007; Rukunga et al., 2009). A 2,4-trans-7,40-
dihydroxymethoxyﬂavan compound has been isolated and
characterized from polar extracts of shredded leaves and twigs
of C. abbreviata. However, the pharmacological effects were
not determined (Dehmlow et al., 1998).
Malan et al. (1996) isolated guibourtinidin dimers from the
bark of C. abbreviata. Acetone extracts of the bark yielded
guibourtinidol-(4bﬁ8)-epicatechin, guibourtinidol-(4aﬁ8)-
epiafzelechin, guibourtinidol-(4aﬁ8)-catechin, guibourtinidol-
(4aﬁ8)-epicatechin and ent-guibourtinidol-(4bﬁ8)-epicatechin
(Malan et al., 1996). From the same research work, a novel
(2R, 3S)-guibourrtinidol, representing the ﬁrst ﬂavan-3-ol with
40, 7-dihydroxy phenolic substitution pattern, was identiﬁed in
the heartwood of C. abbreviata but no biological activity
reported.
Whereas it is clear that crude extracts of different parts of
C. abbreviata have been screened for antiplasmodial activity,
no activity-guided investigation leading to active pure com-
pound has been reported. In this study we investigated the
antiplasmodial effects of the methanolic root extract of C.
abbreviata against two strains of Plasmodium falciparum
namely; the chloroquine-resistant W2 and chloroquine-
sensitive D6 and identiﬁed the active compounds.
2. Materials and methods
2.1. Plant material
The plant parts (roots) of C. abbreviata Oliv. (Fabaceae,
Caesalpinioideae) were collected in July 2003 from Taita
Taveta District in the coastal region of Kenya. The plant
was identiﬁed by Dr. S. T. Kariuki (taxonomist) of the Depart-
ment of Botany, Egerton University. A voucher specimen
(KAR 156) of the plant was deposited at herbarium of the
Department of Botany, Egerton University. The roots were
dried under shade for 2 weeks. The dried roots were further
chopped into small pieces and ground to powder then stored
at room temperature until extraction.
2.2. Extraction and puriﬁcation of active compounds
The dried ground plantmaterial (675 g) was defatted with 5 L of
petroleum ether (40–60 C) (Fig. 1). The petroleum ether frac-
tion was not analyzed further and was discarded. The defatted
material was further extracted with methanol (5 L) in order to
obtain 69 g of crude extract. The crude extract (15 g) was chro-
matographed on 50 g of silica gel 60 (0.063–0.2 mm) using a
glass column with a dimension of 2.5 cm diameter and 10.0 cm
long slurry packed volume. The column was eluted with a sol-
vent system gradient eluent of increasing polarity from 100%
CHCl3 to 100% MeOH to give 25 fractions. Each of the frac-
tions was spotted on thin layer chromatography (TLC) pates(Macherey Nagel, 0.25 mm Dueren). Based on their TLC pro-
ﬁle, ten main fractions were pooled from the 25 eluent fractions
before being bioassayed against P. falciparum D6 and W2
strains. The TLC plates were developed using CHCl3/MeOH
(1:1) solvent system that gave good separation. The plates were
viewed under UV, developed using anisaldehyde (anisaldehyde/
concentrated sulfuric acid (1:1 in 200 ml of methanol) spray re-
agent and then heated at 100 C for 15 min. Using the in vitro
antiplasmodial activity against the D6 and W2 P. falciparum
strains, the 10 main pooled fractions were tested and the most
active fraction was subjected to repeated column chromatogra-
phy until pure compounds were puriﬁed.
2.3. Spectroscopic and spectrometric analysis
NMR spectra (1H and 13C NMR, DEPT-135 and -90) were re-
corded at 30 C on a Bruker instrument operating at 300 MHz
using standard software packages. The pure compounds were
dissolved in deuterated chloroform (CDCl3) for NMR analysis.
Chemical shifts (d) are reported in ppm using the solvent
signal as internal standard. Mass spectra were recorded with
a LXQ linear ion trap instrument (Finnigan) using electrospray
ionization (ESI-MS) in the negative or positive mode. Electron
impact mass spectra (EI-MS) were recorded on a Thermoquest-
Voyager instrument (equipped with a probe-inlet).
2.3.1. Compound 1: 2,3-Dihydro-5-hydroxy-8-methoxy-2-
(4-methoxyphenyl)chromen-4-one
Yellow solid. C17H16O5. ESI-MS, m/z: 323 [M+Na]
+. 1H and
13C NMR: Table 1. Rf = 0.87 in CHCl3/MeOH (1:1 v/v).
2.3.2. Compound 2: 3,4-Dihydro-2-(4-hydroxyphenyl)-
4-methoxy-2H-chromen-7-ol
Brown solid. C16H16O4. ESI-MS, m/z: 295 [M+Na]
+. 1H and
13C NMR: Table 2. Rf = 0.82 in CHCl3/MeOH (1:1 v/v).
2.4. In vitro antiplasmodial activity assay
The puriﬁcation of compounds was guided by antiplasmodial
testing. The [3H]-hypoxanthine incorporation assay was used
to determine the antiplasmodial activity using a semi-
automated micro-dilution technique (Desjardins et al., 1979;
Table 1 1H NMR and 13C NMR data for compound 1.
No Experimental Literature
dC-13 dH dC-13 dH
2 92.6 4.78, dd, J= 12.2 Hz 79.3 5.51, dd, J= 12.2 Hz
3 31.9 2.01, ddd, J= 14.2 Hz, J= 12.3 Hz,
J= 3.0 Hz 2.31, dt, dt; J= 14.3 Hz
43.1 3.38, ddd, J= 14.2 Hz, J= 12.3 Hz,
J= 3.0 Hz 3.13dt, dt; J= 14.3 Hz
4 192.5 – 196.9 –
5 162.7 – 153.6 –
6 109.3 7.85, d, J= 2.1 108.4 6.26, d, J= 2.4
7 119.9 7.72, d, J= 2.1 120.7 6.67, d, J= 2.4
8 137.0 – 142.4 –
9 143.2 – 148.7 –
10 115.8 – 111.3 –
10 128.8 – 133.0 –
20 121.4 7.11, m 128.2 7.08, m
30 133.6 7.27 m 114.5 6.70, m
40 149.3 – 159.6 –
50 124.6 7.72 m 114.5 6.70, m
60 131.0 7.27 m 128.2 7.08, m
8-OCH3 55.7 3.45, s 56.2 3.73, s
40-OCH3 55.2 3.50, s 55.9 3.73, s
5 –OH 12.09 –OH 12.23
d, doublet; s, singlet and m, multiplet.
S142 D.M. Kiplagat et al.Muregi et al., 2003). Two P. falciparum malaria parasite clones
W2 and D6 were utilized in the susceptibility tests for the crude
extracts, the intermediate fractions and puriﬁed compounds.
The W2 clone is resistant to chloroquine, pyrimethamine, sul-
fadoxine and quinine, while D6 is resistant to meﬂoquine but
sensitive to chloroquine (Tchuendem et al., 1999; Odhiambo
and Odulaja, 2005). These isolates were obtained from our fro-
zen sample library, and maintained in continuous culture to
acquire in vitro replication robustness depicted by attainment
of 3–8% parasitemia within eight-days of culture.
The test samples including extracts, fractions and com-
pounds were dissolved in dimethyl sulfoxide (DMSO) in dis-
posable sterile 50 ml culture test tubes (Fischer Scientiﬁc,
Pittsburgh, USA) and sonicated for 10 min. Stock solutions
were prepared at 50 lg/ml concentration each, by diluting
the test sample solutions with complete culture medium with
serum (RPMI 1640). Reference drugs, chloroquine (CQ) and
meﬂoquine (MQ) were dissolved in 70% ethanol and starting
concentrations of 1000 and 250 ng/ml respectively prepared.
These drugs followed by the test samples were put on separate
rows of 96-well microculture plates (catalog # 167008; Nunc
Inc., Roskilde, Denmark) in ﬁrst wells only. Twofold dilution
across the 11 wells was then done to attain a dose range of CQ
(1000–1.953 ng/ml); MQ (250–0.488 ng/ml); test samples
(50,000–97.656 ng/ml) with ﬁnal DMSO concentration <1%
as templates all test extracts and reference standard drugs. Test
plates were prepared by transferring 25 ll aliquots of the
extract from each well to another sterile plate.
For in vitro testing, culture adapted parasites at 3–8% par-
asitemia were lowered to 1% parasitemia at 1% hematocrit
and 200 ll added to pre-dosed drug plates. Negative controls
and positive controls (parasitized red blood cells) were incor-
porated. The plates were incubated for 24 h in 6% CO2 satu-
rated incubator at 37 C. Then 25 ll of [3H]-hypoxanthine
(0.15 lci) was added and further incubated for 18 h. Harvested
cell contents were dried in the oven and thereafter scintillation
ﬂuid was put. Drug effect was measured by differential uptakeof radiolabeled [3H]-hypoxanthine using an automated liquid
scintillation counter (Scintillation and Luminescence counter
Top count NXT v2.3) which generated dose dependent scintil-
lation counts per minute (cpm).
The concentration of the test sample that inhibits 50% of
the cells (IC50 values) was obtained from dose–response
curves, using a non-linear dose–response curve ﬁtting analysis
via GraphPad Prism v.4.00 software. The concentrations were
plotted against scintillation counts per minute (cpm).
2.5. Statistical analysis
Data are expressed as mean ± standard deviation. Statistical
analysis was performed using student t-test. P-values lower
that 0.05 were statistically considered as signiﬁcant.3. Results and discussion
The methanolic root crude extract of C. abbreviata had an
in vitro IC50 value of 13.31 lg/ml against chloroquine-resistant
P. falciparum W2 strain and 20.56 lg/ml against chloroquine-
sensitive P. falciparum D6 strain. According to WHO guide-
lines and previous results from our team (Basco et al., 1994;
Pink et al., 2005; Jonville et al., 2008), antiplasmodial activity
was classiﬁed as follows: highly active at IC50 < 5 lg/ml,
promising at 5–15 lg/ml, moderate at 15–50 lg/ml and inac-
tive at >50 lg/ml. The antiplasmodial activity of the methano-
lic root extract of C. abbreviata was therefore classiﬁed as
promising against W2 and moderate against D6.
Previous antiplasmodial test done for C. abbreviata col-
lected and screened in Malawi showed that the plant had
potentially high antiplasmodial activity. The organic crude ex-
tracts of both leaves and roots of the plant gave the following
activities IC50 = 10.08 and 2.88 lg/ml, respectively (Connelly
et al., 1996). The test for these extracts was done against a multi-
drug resistant strain of P. falciparum, Vietnam–Smith strain
Table 3 In vitro antiplasmodial activity values for chloro-
quine, meﬂoquine, quinine and compounds 1 and 2.
Table 2 1H NMR and 13C NMR data for compound 2.
No Experimental Literature
dC-13 dH dC-13 dH
2 72.6 4.89, dd; J= 12.2 Hz 73.1 5.19, dd; J= 12.2 Hz
3 31.9 2.00, ddd; J= 14.2 Hz, J= 12.3 Hz,
J= 3.0 Hz, 2.31, dt; J= 14.3 Hz
34.9 2.02, ddd; J= 14.1 Hz, J= 12.3 Hz,
J= 3.0 Hz, 2.31, dt; J= 14.3 Hz
4 82.5 4.25, ‘‘t’’; J= 4.9 Hz 72.4 4.25, ‘‘t’’; J= 4.9 Hz
5 137.0 7.72, d J= 8.3 Hz 132.0 7.14, d; J= 8.3 Hz
6 109.3 7.85, d J= 2.3 Hz and 8.4 Hz 107.9 6.44, dd; J= 2.3 and 8.4 Hz
7 162.7 – 155.5 –
8 109.9 6.38, d, J= 2.3 Hz 103.5 6.38, d; J= 2.3 Hz
9 153.2 – 156.3 –
10 115.8 – 113.6 –
10 128.8 – 133.3 –
20 121.4 7.11, m 128.0 6.86, m
30 113.6 7.11, m 115.4 6.86 m
40 159.3 – 157.0 –
50 114.6 7.72, m 115.4 7.33, m
60 131.0 7.27, m 128.0 7.33, m
4-OCH3 56.7 3.24, s 55.8 3.45, s
40-OH 12.43 12.23
7-OH 12.94 12.34
d, doublet; s, singlet and m, multiplet.
Antiplasmodial activity of ﬂavan derivatives from rootbark of Cassia abbreviata Oliv. S143(VI/S). In that study the activity was suspected to be due to the
presence of alkaloids or other polar compounds in the plant
parts. However, there was no pure compound reported from
this screening.
From this research work, bioassay-guided chromatographic
fractionation of the methanolic root crude extract of C. abbre-
viata led to the identiﬁcation of two structurally related com-
pounds 1 and 2 responsible for the observed antiplasmodial
activity (see Fig. 2). Puriﬁcation was, however, focused on
the fraction that showed enrichment of antiplasmodial activity
upon fractionation so as to purify the compounds responsible
for the observed antiplasmodial activity. The crude extract
afforded 10 main fractions, from which the ﬁfth fraction to
be eluted had the strongest antiplasmodial activity. This frac-
tion was repeatedly fractionated using silica gel chromatogra-
phy to afford two compounds 1 and 2. The proposed chemical
structures for the puriﬁed compounds were based on the inter-
pretation of the spectra and compared with reported spectro-
scopic data from the literature.
Compound 1, named 2,3-dihydro-5-hydroxy-8-methoxy-
2-(4-methoxyphenyl)chromen-4-one, was puriﬁed as a yellow
solid (62 mg) and was readily soluble in chloroform, dichloro-
methane and methanol. The 1H NMR, 13C NMR and DEPT
spectra indicated a typical ﬂavanoid basic structure that is
functionalised at positions C-4, C-5, C-8 and C-40 (see
Fig. 2). The 1H NMR spectrum showed a characteristic reso-OHO
OCH3
OH
1
O
OCH3
OH O
OCH3
2
Figure 2 Chemical structures for puriﬁed compounds 1 and 2.nance signal at dH 12.09, corresponding to a phenol OH group
at position C-5 (refer Table 1).
Compound 2 (80 mg) was also puriﬁed from the methanolic
root extract as brown solid that was highly soluble in
chloroform and methanol. The structure of compound 2 was
elucidated and was identiﬁed to be 2,4-trans-7,40-hydroxy-
4-methoxyﬂavan by common name and 3,4-dihydro-2-(4-
hydroxyphenyl)-4-methoxy-2H-chromen-7-ol by IUPAC
naming system. Compound 2 was previously puriﬁed from
shredded leaves and twigs of C. abbreviata. The1H -NMR
and 13C NMR spectral data generated experimentally are sum-
marized in Table 2 and the corresponding literature values gi-
ven (Dehmlow et al., 1998). The bioassay-guided fractionation
process yielded two compounds; (1) (62 mg) and (2) (80 mg)
with the latter having a more improved antiplasmodial activity
(D6 IC50 value of 8.1 ± 0.8 lg/ml and W2 IC50 value of
8.9 ± 2.1 lg/ml) relative to the intermediate fractions and
the crude extract. The chemical structures of compounds 1
and 2 were deduced based on the NMR spectra and EI-MS
values when compared to literature values.
There are no previous reports of compounds 1 and 2 being
investigated for antiplasmodial activity though their structuresCompound Antiplasmodial D6
(IC50 lg/ml) ± S.D.
Antiplasmodial W2
(IC50 lg/ml) ± S.D.
Chloroquine 0.026 0.029
Meﬂoquine 0.030 0.044
Quinine 0.93 0.106
Crude extract 13.31 ± 4.1 20.56 ± 3.2
1 26.02 ± 1.0 25.97 ± 1.0
2 8.12 ± 0.8 8.89 ± 2.1
Control 0 0
S.D., standard deviation.
S144 D.M. Kiplagat et al.reveal that they could be biologically active. The antiplasmo-
dial activities for compounds 1 and 2 are summarized in
Table 3. Compound 1 showed a moderate activity, with IC50
values of 26.02 lg/ml (D6), and 25.97 lg/ml (W2) while com-
pound 2 was more potent with IC50 values of 8.12 lg/ml
(D6), 8.89 lg/ml (W2) good antiplasmodial activity as per
the criterion. The results can be discussed based on a criterion
described by Pink et al. (2005) in which for antiparasitic drug
discovery, a compound can be considered a hit if it is active
in vitro against whole protozoa with an IC50 of 61 lg/ml.
Based on the criterion, both compounds 1 and 2 cannot be
considered hits but active enough to account for the reported
antimalarial activity reported by traditional herbal practice.
4. Conclusion
The identiﬁcation of antiplasmodial ﬂavans from C. abbreviata
suggests that they may play a role in the medicinal properties
of the plant, but their potential for the development of antima-
larial drugs is limited due to their level of activity and the
chemical structures of these classes of compounds.
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